WINDTREE THERAPEUTICS INC /DE/ Foreign Currency Transaction Gain, before Tax
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Foreign Currency Transaction Gain, before Tax of $100.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionGainBeforeTax · last filed 2025-05-15
- WINDTREE THERAPEUTICS INC /DE/ foreign currency transaction gain, before tax for the quarter ending 2025-03-31 was $100.00K, a 50.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ foreign currency transaction gain, before tax for the quarter ending 2024-12-31 was $100.00K.
- WINDTREE THERAPEUTICS INC /DE/ foreign currency transaction gain, before tax for the quarter ending 2024-09-30 was $100.00K, a 50.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ foreign currency transaction gain, before tax for the quarter ending 2024-06-30 was $100.00K, a 0.00% change year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ foreign currency transaction gain, before tax for fiscal 2024 was $300.00K.
- WINDTREE THERAPEUTICS INC /DE/ foreign currency transaction gain, before tax for fiscal 2022 was $700.00K.
| Period end | Foreign Currency Transaction Gain, before Tax 3 month | Foreign Currency Transaction Gain, before Tax 6 month | Foreign Currency Transaction Gain, before Tax 9 month | Foreign Currency Transaction Gain, before Tax 12 month |
|---|---|---|---|---|
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-15 | $200.00K derived: sum of 2 quarters · filed 2025-05-15 | $300.00K derived: sum of 3 quarters · filed 2025-05-15 | $400.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $200.00K derived: sum of 2 quarters · filed 2025-04-15 | $300.00K derived: sum of 3 quarters · filed 2025-04-15 | $300.00K 10-K · filed 2025-04-15 |
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-26 | $200.00K derived: sum of 2 quarters · filed 2024-11-26 | $200.00K 10-Q · filed 2024-11-26 | |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-19 | $300.00K 10-Q · filed 2024-08-19 | ||
| 2024-03-31 | $200.00K 10-Q · filed 2025-05-15 | |||
| 2023-09-30 | $200.00K 10-Q · filed 2024-11-26 | $300.00K derived: sum of 2 quarters · filed 2024-11-26 | $300.00K 10-Q · filed 2024-11-26 | $200.00K derived: sum of 4 quarters · filed 2024-11-26 |
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-19 | $100.00K 10-Q · filed 2024-08-19 | $0.00 derived: sum of 3 quarters · filed 2024-08-19 | $500.00K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-15 | -$100.00K derived: sum of 2 quarters · filed 2024-05-15 | $400.00K derived: sum of 3 quarters · filed 2024-05-15 | $600.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $300.00K derived: sum of 2 quarters · filed 2024-04-16 | $500.00K derived: sum of 3 quarters · filed 2024-04-16 | $700.00K 10-K · filed 2024-04-16 |
| 2022-09-30 | $500.00K 10-Q · filed 2023-11-09 | $700.00K derived: sum of 2 quarters · filed 2023-11-09 | $900.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $200.00K 10-Q · filed 2023-08-07 | $400.00K 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | $200.00K 10-Q · filed 2023-05-15 | |||
| 2021-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $400.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-05 | |||
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |